Experienced business development professional focused on helping to develop tailored solutions for clients, expediting early drug development and streamlining outsourcing strategy through adoption of innovative "Translational Pharmaceutics" model. Proven results with over 50+ companies who have leveraged this approach with documented saving of 6+ months and $2M+ to achieve clinical proof of concept. Applies to all therapeutic areas. Case studies, posters, scientific publications and references available upon request. Please ask about free biopharmaceutical risk assessment and white paper on how to accelerate achieving Target Pharmaceutical Profile and improving chances of success in Phase...